SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950134-01-500869
Filing Date
2001-04-27
Accepted
2001-04-27 00:00:00
Documents
2
Period of Report
2001-04-23
Items
Item 4: Changes in registrant's certifying accountant
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d86593e8-k.txt 8-K 6829
2 LETTER FROM RICHARD A. EISNER & COMPANY, LLP d86593ex16-1.txt EX-16.1 4929
  Complete submission text file 0000950134-01-500869.txt   13390
Mailing Address 9000 HARRY HINES BLVD DALLAS TX 75235
Business Address 9000 HARRY HINES BLVD STE 330 DALLAS TX 75235 2143532922
CYTOCLONAL PHARMACEUTICS INC /DE (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26078 | Film No.: 1614461
SIC: 2834 Pharmaceutical Preparations